MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
MREO - Mereo Biopharma Group Plc
$4.02
0.17(4.42%)9:00:00 PM 2/24/2021
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company also develops Navicixizumab (OMP-305B83) that is in Phase 1a clinical trial for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that has completed Phase II clinical trial to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody, which is in Phase IIb clinical trial for the treatment of osteogenesis imperfect; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. Mereo BioPharma Group plc was founded in 2015 and is based in London, the United Kingdom.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • MACD is crossing MACD signal line at 0.1. MACD crossing signal line is bullish signal.
Stock Statistics
MarketCap413.9M
PE Ratio
PEG Ratio
P/B
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %0%
Held by Institutions %22%
1 Day Vol Adjusted Return0.7
1 Month Vol Adjusted Return5.2
3 Month Vol Adjusted Return7.4
6 Month Vol Adjusted Return3.7
20 Days SMA Price ZScore1.3
50 Days SMA Price ZScore1.5
12 -26 Days PPO8.3
1 Month Average Short Volume Ratio46.3
1 Day Volume Change ZScore-0.3
1 Month Daily Vol6.3
Related Topics
leak data

Related Topics

Stock news